Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04928924Unknown

Immediate Post-THA Functional Assessment

Role: collaborator

NCT02905097Unknown

Post-marketing Surveillance Study of the Triathlon Tritanium Baseplate

Role: collaborator

NCT00715325Phase 1Unknown

ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy

Role: lead

All 3 trials loaded